Medscape BOSTON, MA ( updated ) — Authors of a new meta-analysis comparing a bivalirudin (Angiomax, the Medicines Company)-based regimen vs a heparin -based approach in...
Scientific American Clots are clumps of blood cells, platelets and proteins, and so it seemed logical to think that diluting, or thinning, the blood with heparin would...
Ubyssey Online Kizhakkedathu said that one to three percent of the global population uses heparin . It is not only used for the regular treatment of cardiovascular disease such as venous or arterial thromboembolism but also in most surgeries and all dialysis procedures.
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
MedPage Today SAN FRANCISCO -- A novel anti-factor XI agent prevented venous thrombosis in knee replacement in some ways better than low-molecular-weight heparin and with no significant differences in rates of bleeding, phase II trial results showed. Injections of ... and more »
TCTMD The risks of MACE at 30 days (primary efficacy endpoint; death, MI, urgent TVR or TLR, or stroke) each were higher with unfractionated heparin , bivalirudin, and fondaparinux alone compared with unfractionated heparin plus GPI and LMWH plus GPI ... and more »
WhaTech In terms of the proposed/ongoing projects, however, it is projected that the heparin API in China will achieve an additional capacity of more than 20 trillion units by 2015, when China's total capacity will exceed 30 trillion units, accounting for ...
In-PharmaTechnologist.com Heparin production may be moving back to Europe according to the EFCG, which cited the opening of Pharma Action's processing plant as an indication that API buyers value quality and compliance throughout the supply chain. and more »
Newswise (press release) Newswise — Hamilton, ON (Nov. 18, 2014) – McMaster University researchers have found new evidence that suggests patients with a history of adver...
